Paraprobiotic Lactiplantibacillus plantarum MYO ameliorates dexamethasone-induced muscle atrophy: implications for age-related sarcopenia.

Meehee Park, Sun-Young Ryu, Hyeon Jeong Kim, Duseong Kim, Ji-Won Song, Seunghun Lee, Jisoo Park

Mitos Biomedical Institute, Mitos Therapeutics Inc, Daejeon, Republic of Korea.Mitos Biomedical Institute, Mitos Therapeutics Inc, Daejeon, Republic of Korea. · pubmed

Paper

Abstract

Sarcopenia, characterized by the progressive age-related decline in skeletal muscle mass, strength, and function, represents a major unmet need in geriatric health. Effective and safe interventions to prevent or ameliorate muscle atrophy are urgently required.

The following analysis is generated by AI and may contain errors. It is separate from the authors’ abstract and is not peer review.

Research summary

The paper claims that the paraprobiotic Lactiplantibacillus plantarum MYO can ameliorate muscle atrophy induced by dexamethasone. This research addresses sarcopenia, a significant age-related condition, and explores potential interventions that could contribute to healthier aging.

Author of this paper? Send a correction.